State of Alaska, Department of Revenue - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$542
+1.9%
6,060
-3.1%
0.01%
+16.7%
Q2 2023$532
-7.5%
6,255
-10.0%
0.01%
-14.3%
Q1 2023$575
+2.7%
6,952
-2.4%
0.01%0.0%
Q4 2022$560
-99.9%
7,1230.0%0.01%0.0%
Q3 2022$527,000
+10.3%
7,123
-3.0%
0.01%
+16.7%
Q2 2022$478,000
+3.7%
7,343
+0.6%
0.01%
+20.0%
Q1 2022$461,000
+17.6%
7,298
-1.4%
0.01%
+25.0%
Q4 2021$392,000
-31.0%
7,398
-8.1%
0.00%
-33.3%
Q3 2021$568,000
+7.8%
8,048
+1.7%
0.01%
+20.0%
Q2 2021$527,000
-40.3%
7,913
-0.6%
0.01%
-50.0%
Q1 2021$883,000
-9.8%
7,963
-3.5%
0.01%
-9.1%
Q4 2020$979,000
+29.7%
8,251
-4.7%
0.01%
+22.2%
Q3 2020$755,000
-5.9%
8,655
-3.4%
0.01%
-10.0%
Q2 2020$802,000
-7.8%
8,960
+2.6%
0.01%
-28.6%
Q1 2020$870,000
-9.1%
8,733
+4.8%
0.01%
+16.7%
Q4 2019$957,000
-15.9%
8,334
-7.7%
0.01%
-20.0%
Q3 2019$1,138,000
+161.6%
9,028
+137.6%
0.02%
+114.3%
Q3 2018$435,000
-65.5%
3,800
-78.0%
0.01%
-73.1%
Q1 2018$1,261,000
+106.4%
17,248
+63.8%
0.03%
+73.3%
Q4 2017$611,000
+30.8%
10,528
+1.1%
0.02%
-37.5%
Q3 2017$467,000
+14.2%
10,418
+0.6%
0.02%
-14.3%
Q2 2017$409,000
+76.3%
10,358
+80.5%
0.03%
+64.7%
Q1 2017$232,000
+3.1%
5,740
+2.3%
0.02%
-22.7%
Q4 2016$225,0005,6100.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders